04:19

The Microbe Manipulation Hypothesis: How Microbes May Influence Behavior and Free Will

04:50

How Clinical Labs Help Detect Outbreaks and Prevent Infectious Diseases

04:51

COVID-19 Variants and Vaccine Decisions Heading Into Fall

05:31

Danish Study Finds No Increased Risk from Aluminum-Containing Childhood Vaccines

04:42

Pandemics, Pathogens, and the Psychology of Violence

04:56

Merck’s MK-8527 Advances to Phase 3 for Once-Monthly HIV Prevention

05:41

Carl Schmid on Supreme Court Ruling Upholding ACA Preventive Coverage & Its Impact on HIV Prevention

07:52

FDA Approves Gilead’s Twice-Yearly Injectable Lenacapavir (Yeztugo) for HIV Prevention

04:32

Merck’s Enflonsia Receives FDA Approval to Protect Infants From RSV During First Season

04:26

Precision in Practice: PK/PD Modeling Advances Infectious Disease Care

04:24

Microbiota-Based Therapy Improves Mental Quality of Life in rCDI Trial

26:40

Test Determines Between Bacterial and Viral Infections in 15 Minutes

04:50

FDA Approves F8 Formulation of Theratechnologies' Tesamorelin for HIV-Associated Lipodystrophy

24:19

Identifying Invasive Pneumococci in Pediatric Infections Utilizing Whole Genome Sequencing

06:09

Gilead's Once Yearly Lenacapavir Formulations Show Sustained Efficacy for HIV PrEP in Phase 1 Study

04:38

Retinal Biomarkers Reveal Vascular Changes in Long COVID

06:26

Emerging Threats and Key Knowledge From 2024 Trending Into 2025

23:06

From Pathogen to Infectious Disease Diagnosis: Identifying a Novel Variant of Klebsiella Pneumoniae

07:25

US Health Policy Changes Threaten Global Public Health Cooperation

04:31

Five All-Oral Regimens Show Efficacy in the Phase 3 endTB Trial for Rifampin-Resistant TB

03:12

Dusty Fungal Threat: Valley Fever Spreads as Conditions Change

05:43

Fungal Infections: Invisible Until It’s Too Late

05:03

NACCHO's Efforts to Combat Healthcare-Associated Infections and Antimicrobial Resistance

17:02

From Pathogen to Infectious Disease Diagnosis: Medical Tourism and an Outbreak of Fungal Meningitis

05:14

Fighting C difficile Before It Starts: Lopoxy Therapeutics Approach

06:30

CACTUS Study Compares Ceftolozane-Tazobactam vs. Ceftazidime-Avibactam for MDR Pseudomonas

16:43

Taking on Potential Standard-of-Care Diagnostic Opportunities

05:49

mRNA Vaccine Shows Potential for C difficile Infections

04:35

Navigating Long COVID and ME/CFS Overlap

08:28

More Bugs, No Drugs: The Growing Threat of Antibiotic Resistance

04:42

Imdusiran for Chronic Hepatitis B Achieves Functional Cure in 50% of Patients

05:42

GigaGen Doses 1st Patient in Phase 1 Trial of GIGA-2339, Potential Functional Cure for Chronic HBV

21:02

From Pathogen to Infectious Disease Diagnosis

06:28

Merck's Clesrovimab Shows Effectiveness in RSV Prevention for Infants

07:36

Rebuilding Trust in Intranasal Vaccines for Avian Flu and Other Respiratory Diseases

09:40

Photohydrolysis Technology Reduces in Fungal Colony-Forming Units and C auris In Hospital Settings

04:46

Insights on Universal Hepatitis B Screening and Treatment Guidelines

13:01

Exploring The Challenges and Insights in Long COVID Treatment and Management

11:46

Unmasking Long COVID Through Understanding Prevalence and Diagnosis

04:35

Transformative Potential of Wastewater Surveillance in Monitoring Antimicrobial Resistance

07:18

Advocating for Better Regulatory Rules and Standard of Care for C difficile

06:07

Strategies for Improving Pandemic Preparedness

04:49

The Roles of Misinformation, Disinformation, and Confirmation Bias in Public Health Discourse

03:43

Sepsis Awareness Month: Highlighting the Findings from BLINGIII Trial

04:18

Does COVID-19 Make a Better Case for Vaccines?

07:04

What Should Be Achieved in Phase 3 COVID-19 Vaccine Trials?

09:07

What to Make of the AstraZeneca COVID-19 Vaccine Trial Stalls

22:28

NIH: Expanding Trials for Convalescent Plasma

06:16

Average US COVID-19 Patient Age is Dropping

07:37

How Will COVID-19 Vaccines Be Distributed and Stored?

22:18

Innovative Device Looks to Filter Viruses

06:07

An Infectious Disease Expert Argues for ACA During COVID-19

11:57

Targeting Lung Blood Vessel Inflammation, Injury in COVID-19 Patients

05:33

Reaching a Majority in US COVID-19 Needs

06:48

COVID-19 Public Health Messaging Needs to Improve

08:09

Dialysis Data for SARS-CoV-2 Antibody Monitoring

26:16

Texas State Scientist on Rabies Eradication, Campus Reopening, and AMR

03:58

Safety Measures in Vaccine Related Clinic Visits During COVID-19

12:26

How COVID-19 Impacted Antibiotic Resistance | Dr. Debra Goff

09:08

Lessons Learned from One of the Earliest Cases of MIS-C